e677c8eb4652a38853b8bf93b419beea  pdf_223420.pdf
9ad2d6ebd908545ccdffe1fc99b2d6d68ce4a92f  pdf_223420.pdf
e463ff4e36f4b258a70765bbda989ba984449a67afd242693e0bad2844aa4c05  pdf_223420.pdf

Title:          Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma
Subject:        In the last 10 years, major advances have been made in the diagnosis and development of selective therapies for several blood cancers, including B-cell non-Hodgkin lymphoma (B-NHL), a heterogeneous group of malignancies arising from the mature B lymphocy
Keywords:       B-cell lymphoma, DNMT, EZH2, HDAC, PRMT inhibitor, BET bromodomain inhibitor (BETi), combination therapy
Author:         Marcelo L. Ribeiro
Creator:        Adobe InDesign CC 2015 (Windows)
Producer:       Adobe PDF Library 15.0
CreationDate:   Tue Oct 15 22:25:23 2019 CEST
ModDate:        Tue Feb 23 16:04:26 2021 CET
Tagged:         yes
UserProperties: no
Suspects:       no
Form:           none
JavaScript:     no
Pages:          24
Encrypted:      no
Page size:      595.276 x 779.528 pts
Page rot:       0
File size:      1865546 bytes
Optimized:      yes
PDF version:    1.4


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
HelveticaNeueLTStd-Bd                Type 1C           Custom           yes no  yes   3670  0
HelveticaNeueLTStd-BdIt              Type 1C           WinAnsi          yes no  yes   3671  0
HelveticaNeueLTStd-LtIt              Type 1C           Custom           yes no  yes   3672  0
HelveticaNeueLTStd-MdIt              Type 1C           WinAnsi          yes no  yes   3681  0
HelveticaNeueLTStd-Lt                Type 1C           Custom           yes no  yes   3682  0
MinionPro-Regular                    Type 1C           Custom           yes no  yes   3687  0
MinionPro-Bold                       Type 1C           Custom           yes no  yes   3692  0
MinionPro-It                         Type 1C           Custom           yes no  yes    215  0
BCXQKW+STIXGeneral                   Type 1C           Custom           yes yes yes    222  0


Jhove (Rel. 1.22.1, 2019-04-17)
 Date: 2021-03-03 02:22:17 CET
 RepresentationInformation: pdf_223420.pdf
  ReportingModule: PDF-hul, Rel. 1.12.1 (2019-04-17)
  LastModified: 2021-02-23 16:04:45 CET
  Size: 1865546
  Format: PDF
  Version: 1.4
  Status: Well-Formed, but not valid
  SignatureMatches:
   PDF-hul
  ErrorMessage: Annotation object is not a dictionary
   Offset: 4790
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 3770
   FreeObjects: 3380
   IncrementalUpdates: 1
   DocumentCatalog: 
    ViewerPreferences: 
     HideToolbar: false
     HideMenubar: false
     HideWindowUI: false
     FitWindow: false
     CenterWindow: false
     DisplayDocTitle: false
     NonFullScreenPageMode: UseNone
     Direction: L2R
     ViewArea: CropBox
     ViewClip: CropBox
     PrintArea: CropBox
     PageClip: CropBox
    PageLayout: SinglePage
    PageMode: UseOutlines
    Outlines: 
     Item: 
      Title: Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma
      Children: 
       Item: 
        Title: Introduction
        Children: 
         Item: 
          Title: Characteristics of B-Cell Non-Hodgkin Lymphoma (B-NHL)
         Item: 
          Title: Altered Chromatin-Modifying Enzymes 
in B-NHL
       Item: 
        Title: Targeting Writer Epigenetic Enzymes
        Children: 
         Item: 
          Title: DNMT Inhibitors
         Item: 
          Title: EZH2 Inhibitors
         Item: 
          Title: PRMT Inhibitors
       Item: 
        Title: Targeting Eraser Epigenetic Enzymes: HDAC Inhibitors
       Item: 
        Title: Targeting Reader Epigenetic Enzymes
        Children: 
         Item: 
          Title: BET Inhibitors
         Item: 
          Title: Non-BET Bromodomain-Containing Proteins: the Histone Acetyltransferase CREB-Binding Protein (CBP)
       Item: 
        Title: Chromatin Remodelers: SWI/SNF and BRG1 and ARID1
       Item: 
        Title: Indirect Inhibition of Epigenetic Dysregulation by IDH Inhibitors
       Item: 
        Title: Combination Involving Epigenetic-Targeting Approaches
        Children: 
         Item: 
          Title: Concomitant Targeting of Different Epigenetic Modulators
         Item: 
          Title: Combination of Epigenetic Drugs With Other Classes of Anti-Tumoral Drugs
       Item: 
        Title: Conclusions
       Item: 
        Title: Author Contributions
       Item: 
        Title: Funding
       Item: 
        Title: References
   Info: 
    Title: Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma
    Author: Marcelo L. Ribeiro
    Subject: In the last 10 years, major advances have been made in the diagnosis and development of selective therapies for several blood cancers, including B-cell non-Hodgkin lymphoma (B-NHL), a heterogeneous group of malignancies arising from the mature B lymphocy
    Keywords: B-cell lymphoma, DNMT, EZH2, HDAC, PRMT inhibitor, BET bromodomain inhibitor (BETi), combination therapy
    Creator: Adobe InDesign CC 2015 (Windows)
    Producer: Adobe PDF Library 15.0
    CreationDate: Tue Oct 15 22:25:23 CEST 2019
    ModDate: Tue Feb 23 16:04:26 CET 2021
   ID: 0x5c0265e015e10f468c6b3ffed9e4989d, 0x32fcece49d0fea41810e9deadfa4ad40
   Filters: 
    FilterPipeline: FlateDecode
    FilterPipeline: DCTDecode
   Images: 
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 980
      ImageHeight: 614
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
     Intent: RelativeColorimetric
     Name: X
    Image: 
     NisoImageMetadata: 
      FormatName: image/png
      ImageWidth: 980
      ImageHeight: 621
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
     Filter: FlateDecode
     Intent: RelativeColorimetric
     Name: X
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 2000
      ImageHeight: 996
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
     Intent: RelativeColorimetric
     Name: X
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 2000
      ImageHeight: 1782
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
     Intent: RelativeColorimetric
     Name: X
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 2000
      ImageHeight: 2280
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
     Intent: RelativeColorimetric
     Name: X
   Fonts: 
    Type1: 
     Font: 
      BaseFont: HelveticaNeueLTStd-MdIt
      FirstChar: 0
      LastChar: 255
      FontDescriptor: 
       FontName: HelveticaNeueLTStd-MdIt
       Flags: Nonsymbolic, Italic
       FontBBox: -165, -218, 1125, 947
       FontFile3: true
      Encoding: WinAnsiEncoding
      ToUnicode: true
     Font: 
      BaseFont: HelveticaNeueLTStd-Lt
      FirstChar: 0
      LastChar: 255
      FontDescriptor: 
       FontName: HelveticaNeueLTStd-Lt
       Flags: Nonsymbolic
       FontBBox: -166, -214, 1050, 967
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: HelveticaNeueLTStd-Bd
      FirstChar: 0
      LastChar: 255
      FontDescriptor: 
       FontName: HelveticaNeueLTStd-Bd
       Flags: Nonsymbolic
       FontBBox: -166, -218, 1078, 975
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: MinionPro-Regular
      FirstChar: 0
      LastChar: 255
      FontDescriptor: 
       FontName: MinionPro-Regular
       Flags: Serif, Nonsymbolic
       FontBBox: -290, -360, 1684, 989
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: HelveticaNeueLTStd-BdIt
      FirstChar: 0
      LastChar: 255
      FontDescriptor: 
       FontName: HelveticaNeueLTStd-BdIt
       Flags: Nonsymbolic, Italic
       FontBBox: -166, -218, 1129, 975
       FontFile3: true
      Encoding: WinAnsiEncoding
      ToUnicode: true
     Font: 
      BaseFont: MinionPro-It
      FirstChar: 0
      LastChar: 255
      FontDescriptor: 
       FontName: MinionPro-It
       Flags: Serif, Nonsymbolic, Italic
       FontBBox: -201, -360, 1684, 1002
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: HelveticaNeueLTStd-LtIt
      FirstChar: 0
      LastChar: 255
      FontDescriptor: 
       FontName: HelveticaNeueLTStd-LtIt
       Flags: Nonsymbolic, Italic
       FontBBox: -165, -214, 1099, 951
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: MinionPro-Bold
      FirstChar: 0
      LastChar: 255
      FontDescriptor: 
       FontName: MinionPro-Bold
       Flags: Serif, Nonsymbolic
       FontBBox: -319, -360, 1684, 1024
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: BCXQKW+STIXGeneral
      FontSubset: true
      FirstChar: 30
      LastChar: 31
      FontDescriptor: 
       FontName: BCXQKW+STIXGeneral
       Flags: Serif, Nonsymbolic
       FontBBox: -178, -443, 2000, 1023
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 5.6-c017 91.164464, 2020/06/15-10:20:05        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/"
            xmlns:xmp="http://ns.adobe.com/xap/1.0/"
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/"
            xmlns:stRef="http://ns.adobe.com/xap/1.0/sType/ResourceRef#"
            xmlns:stEvt="http://ns.adobe.com/xap/1.0/sType/ResourceEvent#"
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <dc:format>application/pdf</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">In the last 10 years, major advances have been made in the diagnosis and development of selective therapies for several blood cancers, including B-cell non-Hodgkin lymphoma (B-NHL), a heterogeneous group of malignancies arising from the mature B lymphocy</rdf:li>
            </rdf:Alt>
         </dc:description>
         <dc:creator>
            <rdf:Bag>
               <rdf:li>Marcelo L. Ribeiro</rdf:li>
               <rdf:li>Diana Reyes-Garau</rdf:li>
               <rdf:li>Marc Armengol</rdf:li>
               <rdf:li>Miranda Fernández-Serrano</rdf:li>
               <rdf:li>Gaël Roué</rdf:li>
            </rdf:Bag>
         </dc:creator>
         <dc:subject>
            <rdf:Bag>
               <rdf:li>B-cell lymphoma</rdf:li>
               <rdf:li>DNMT</rdf:li>
               <rdf:li>EZH2</rdf:li>
               <rdf:li>HDAC</rdf:li>
               <rdf:li>PRMT inhibitor</rdf:li>
               <rdf:li>BET bromodomain inhibitor (BETi)</rdf:li>
               <rdf:li>combination therapy</rdf:li>
            </rdf:Bag>
         </dc:subject>
         <xmp:CreateDate>2019-10-16T04:25:23+08:00</xmp:CreateDate>
         <xmp:MetadataDate>2021-02-23T16:04:26+01:00</xmp:MetadataDate>
         <xmp:ModifyDate>2021-02-23T16:04:26+01:00</xmp:ModifyDate>
         <xmp:CreatorTool>Adobe InDesign CC 2015 (Windows)</xmp:CreatorTool>
         <xmpMM:InstanceID>uuid:b41c1be3-9549-41af-b9fd-04cb8bd1175d</xmpMM:InstanceID>
         <xmpMM:OriginalDocumentID>xmp.did:2aecd8bd-cbd3-4539-b083-9de383973cbe</xmpMM:OriginalDocumentID>
         <xmpMM:DocumentID>xmp.id:e911fb14-9180-c94d-9b8c-e710694c4644</xmpMM:DocumentID>
         <xmpMM:RenditionClass>proof:pdf</xmpMM:RenditionClass>
         <xmpMM:DerivedFrom rdf:parseType="Resource">
            <stRef:instanceID>xmp.iid:6810b77b-a562-f346-92e9-5907c988eb9d</stRef:instanceID>
            <stRef:documentID>xmp.did:48c0fc82-a37f-5f4b-bdfc-6e238fb522f5</stRef:documentID>
            <stRef:originalDocumentID>xmp.did:2aecd8bd-cbd3-4539-b083-9de383973cbe</stRef:originalDocumentID>
            <stRef:renditionClass>default</stRef:renditionClass>
         </xmpMM:DerivedFrom>
         <xmpMM:History>
            <rdf:Seq>
               <rdf:li rdf:parseType="Resource">
                  <stEvt:action>converted</stEvt:action>
                  <stEvt:parameters>from application/x-indesign to application/pdf</stEvt:parameters>
                  <stEvt:softwareAgent>Adobe InDesign CC 2015 (Windows)</stEvt:softwareAgent>
                  <stEvt:changed>/</stEvt:changed>
                  <stEvt:when>2019-10-16T04:25:23+08:00</stEvt:when>
               </rdf:li>
            </rdf:Seq>
         </xmpMM:History>
         <pdf:Producer>Adobe PDF Library 15.0</pdf:Producer>
         <pdf:Trapped>False</pdf:Trapped>
         <pdf:Keywords>B-cell lymphoma, DNMT, EZH2, HDAC, PRMT inhibitor, BET bromodomain inhibitor (BETi), combination therapy</pdf:Keywords>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
  Checksum: 7730c825
   Type: CRC32
  Checksum: e677c8eb4652a38853b8bf93b419beea
   Type: MD5
  Checksum: 9ad2d6ebd908545ccdffe1fc99b2d6d68ce4a92f
   Type: SHA-1